SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-112596
Filing Date
2023-10-30
Accepted
2023-10-30 16:30:57
Documents
2
Period of Report
2023-10-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2328975-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2328975-2_3seq1.xml 3 1637
2 EXHIBIT 24 tm2328975d2_ex24.htm EX-24 6153
  Complete submission text file 0001104659-23-112596.txt   9412
Mailing Address C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Swisher Daniel N JR (Reporting) CIK: 0001323113 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37852 | Film No.: 231360740

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations